ANDA 061894

LILLY

FDA Drug Application

Application #061894

Application Sponsors

ANDA 061894

LILLY

Marketing Status

• Discontinued: 001
• Discontinued: 002
• Discontinued: 003

Application Products

001	SUSPENSION;ORAL	EQ 125MG BASE/5ML	0	ILOSONE	ERYTHROMYCIN ESTOLATE
002	SUSPENSION;ORAL	EQ 250MG BASE/5ML	0	ILOSONE	ERYTHROMYCIN ESTOLATE
003	SUSPENSION/DROPS;ORAL	EQ 100MG BASE/ML	0	ILOSONE	ERYTHROMYCIN ESTOLATE

FDA Submissions

	ORIG	1	AP	1975-01-07
MANUF (CMC); Manufacturing (CMC)	SUPPL	6	AP	1990-04-10
MANUF (CMC); Manufacturing (CMC)	SUPPL	8	AP	1990-04-10
LABELING; Labeling	SUPPL	9	AP	1991-11-13
LABELING; Labeling	SUPPL	10	AP	1991-09-05
LABELING; Labeling	SUPPL	11	AP	1990-04-16
LABELING; Labeling	SUPPL	12	AP	1991-01-14
LABELING; Labeling	SUPPL	13	AP	1991-11-13
MANUF (CMC); Manufacturing (CMC)	SUPPL	14	AP	1992-01-27
LABELING; Labeling	SUPPL	19	AP	1997-07-22

Submissions Property Types

ORIG	1	Null	0
SUPPL	6	Null	0
SUPPL	8	Null	0
SUPPL	9	Null	0
SUPPL	10	Null	0
SUPPL	11	Null	0
SUPPL	12	Null	0
SUPPL	13	Null	0
SUPPL	14	Null	0
SUPPL	19	Null	0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 61894
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)